MEDPLUS NSE filing

Medplus Health Services Ltd. Submits SEBI Regulation 74(5) Certificate for Q4 FY26

The RealCase readLow impact Neutral

Medplus Health Services Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The certificate was received from Registrar and Transfer Agents, KFIN Technologies Limited, confirming compliance. The details are available on the company and stock exchange websites.

Why it matters

This is a standard regulatory compliance filing for the quarter-end and does not contain any new financial information or strategic decisions that would significantly impact the company's operations or stock performance.

The market read

The announcement is a routine regulatory filing confirming compliance with SEBI regulations and does not contain any material financial or operational information that would impact the company's stock.

Medplus Health Services Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended March 31, 2026.

The certificate was received from KFIN Technologies Limited, the company's Registrar and Transfer Agents. It confirms compliance with the specified SEBI regulations regarding the dematerialization and rematerialization of securities during the quarter.

The company has made this information available on its official website, www.medplusindia.com, as well as on the websites of the BSE Limited (www.bseindia.com) and the National Stock Exchange of India Ltd. (www.nseindia.com). The submission ensures transparency and regulatory adherence for stakeholders.

Filing to action

What to do with a filing like this

Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.

View original filing